InVitro International engages in development and commercialization globally of test kits and laboratory services. The company is headquartered in Placentia, California. The Company’s testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its technologies are commercialized through test kits and laboratory services globally. The firm operates in multiple industry segments providing in-vitro (non-animal) consumer, product, and environmental safety test method to customers in the cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation industries. The company sells three proprietary in vitro products: Ocular Irritection used to evaluate the potential for ocular irritation, Irritection Dermal used to evaluate the potential for dermal irritation, and Corrositex used to determine corrosivity level classifications. The company sells its products to independent distributors, contract laboratories, and end users.
Follow-Up Questions
Quel est le ratio P/E de Invitro International (IVRO) ?
Le ratio P/E de Invitro International est de 236.0142
Qui est le CEO de Invitro International ?
W. Richard Ulmer est le President de Invitro International, il a rejoint l'entreprise depuis 1994.
Quelle est la performance du prix de l'action IVRO ?
Le prix actuel de IVRO est de $0.0645, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Invitro International ?
Invitro International appartient à l'industrie N/A et le secteur est N/A
Quelle est la capitalisation boursière de Invitro International ?
La capitalisation boursière actuelle de Invitro International est de $1.4M
